Clinical Trials Insight: 700028502
Phase of Trial: Phase I
Latest Information Update: 15 Nov 2007
At a glance
- Drugs LU AA 47070 (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Lundbeck A/S
- 15 Nov 2007 New trial record.
- 13 Nov 2007 Status changed to recruiting.